{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:19:35Z","timestamp":1760548775738},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"vor","delay-in-days":6938,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[1990,1]]},"abstract":"<jats:p>To study the effects on plasma proteins, blood coagulation and fibrinolysis of dextran\u201060, given as plasma volume substitute in a 3% solution, 57 patients were studied preoperatively and for 8 days postoperatively in conjunction with elective orthopaedic surgery. Three groups were formed according to the blood loss during the day of surgery: Group I (<jats:italic>n<\/jats:italic>=22) &lt;30%, Group II (<jats:italic>n<\/jats:italic>=24) 30\u201350% and Group III (<jats:italic>n<\/jats:italic>=11) &gt; 50% of the estimated blood volume. Dilution to a haemoglobin concentration of 110 g \u00b7 1<jats:sup>\u20101<\/jats:sup> was intended and erythrocytes transfused accordingly. No platelets were transfused. All patients received similar amounts of crystalloids. Nine patients in Group III received plasma and\/or albumin solution for further volume replacement once the maximum dose of dextran (1.5 g \u00b7 kg<jats:sup>\u20101<\/jats:sup>) was reached. Dextran\u201070 was given on days I and 3 postoperatively for thromboprophylaxis. No patient exhibited clinical signs of thrombosis or embolism. Mean postoperative bleeding times were longer than preoperatively, but still within the normal range in all groups. They were both pre\u2010 and postoperatively slightly longer in Group III, compared to the other groups, perhaps due to mild haemostatic disorders and\/or undisclosed antiphlogistic therapy. Postoperative colloid osmotic pressures decreased by 11\u201319% in the three groups. Dilution of plasma constituents was also seen in the postoperative fall of platelet counts and of albumin, antithrombin and Factor X levels, most marked in Group III. Albumin levels on day 8 were still only 77\u201383% of preoperative values. IgG and IgM were decreased and the IgG level was still only 75% of preoperative on day 8. Dilution of other plasma proteins, e.g. von Willebrand Factor, C\u2010Reactive Protein and Factor VIII:C, were offset by their function as acute phase reactants, with an 8\u2010to\u201010\u2010fold increase of CRP on day 3 and a two\u2010fold increase of F VIII:C on day 8. An activation of the coagulation and fibrinolytic systems not only immediately postoperatively, but also extending up to the eighth postoperative day, was shown by elevations of fibrinopeptide A and D\u2010dimer levels in all groups. We conclude that 3% dextran\u201060 in doses not exceeding 1.5 g \u00b7 kg<jats:sup>\u20101<\/jats:sup> can be safely used for plasma volume replacement in surgery, provided there are no preoperative haemostatic disorders. Our findings also indicate that thromboprophylaxis should be continued until at least the eighth postoperative day.<\/jats:p>","DOI":"10.1111\/j.1399-6576.1990.tb03035.x","type":"journal-article","created":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T08:53:07Z","timestamp":1230799987000},"page":"21-29","source":"Crossref","is-referenced-by-count":20,"title":["Plasma substitution with 3% dextran\u201060 in orthopaedic surgery: influence on plasma colloid osmotic pressure, coagulation parameters, immunoglobulins and other plasma constituents"],"prefix":"10.1111","volume":"34","author":[{"given":"A.","family":"Bergman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Andreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Blomb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,30]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"265","volume-title":"Blood substitutes and plasma expanders","author":"Thor\u00ebn L.","year":"1978"},{"key":"e_1_2_1_3_2","first-page":"253","article-title":"Adverse reactions to dextran in Sweden 1970\u20131979","volume":"149","author":"Ljungstr\u00f6m K\u2010G","year":"1983","journal-title":"Acta Chir Scand"},{"key":"e_1_2_1_4_2","first-page":"355","article-title":"Prevention of dextran\u2010induced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20 ml dextran 1, 15%, administered before dextran 70 or dextran 40","volume":"149","author":"Renck H.","year":"1983","journal-title":"Acta Chir Scand"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1985.tb02298.x"},{"key":"e_1_2_1_6_2","first-page":"147","article-title":"Component therapy of surgical hemorrhage: red cell concentrates, colloids and crystalloids","volume":"46","author":"Lundsgaard\u2010Hansen P.","year":"1980","journal-title":"Bibl Haematol"},{"key":"e_1_2_1_7_2","first-page":"633","article-title":"Dextran and haemostasis","volume":"148","author":"Bergqvist D.","year":"1982","journal-title":"Acta Chir Scand"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91687-2"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365517209102748"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1974.tb05611.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365518009091975"},{"issue":"40","key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.1984.tb02556.x","article-title":"Assay of Factor VIII:C with a chromogenic substrate","volume":"33","author":"Ros\u00e9n S.","year":"1984","journal-title":"Scand J Haematol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(78)90324-9"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(77)90208-0"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(80)90031-6"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(83)90108-1"},{"issue":"33","key":"e_1_2_1_17_2","first-page":"5","article-title":"Colloids versus crystalloids as volume substitutes: clinical relevance of the serum oncotic pressure","volume":"13","author":"Lundsgaard\u2010Hansen P.","year":"1981","journal-title":"Ann Clin Res"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1971.01350070074017"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1068235"},{"key":"e_1_2_1_20_2","first-page":"37","article-title":"Serum levels of IgG and C3, postoperative infections, and blood component therapy","volume":"46","author":"Pappova E.","year":"1980","journal-title":"Bibl Haematol"},{"key":"e_1_2_1_21_2","first-page":"54","volume-title":"Plasma proteins","author":"Birke G.","year":"1979"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01658463"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197902000-00017"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/17453678709146472"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(80)90167-X"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-0038-1657352","article-title":"Pre\u2010 and postoperative levels of Antithrombin III with special reference to thrombo\u2010embolism after total hip replacement","volume":"49","author":"Fredin H.","year":"1983","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_27_2","first-page":"997","article-title":"Editorial: The bleeding\u2010time and the haematocrit","year":"1984","journal-title":"Lancet"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.2.454.454"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(87)90170-8"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.1990.tb03035.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.1990.tb03035.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T19:27:35Z","timestamp":1698002855000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.1990.tb03035.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["10.1111\/j.1399-6576.1990.tb03035.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.1990.tb03035.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"value":"0001-5172","type":"print"},{"value":"1399-6576","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,1]]}}}